These results confirmed that cryptic ZDHHC16 isoform detection can be used as a surrogate marker to identify SF3B1 mutations that alter the profile of 3’ss selection in CLL patient samples. The gene discussed is SF3B1; the disease is B-cell chronic lymphocytic leukemia.